Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

March
13
2020

Melanoma Skin Cancer Early Detection Success Rates

Not only is skin cancer the most common form of cancer diagnosed in the United States, but there are more new cases of skin cancer each year than breast, prostate, lung and colon cancers combined….

March
06
2020

Superficial Radio Therapy – What to Expect During Treatment

You find a spot on your skin that is causing suspicion. It might be a scab that’s been there for too long, an ingrown hair, or a sunspot you’re just not sure about. So, you…

March
03
2020

Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radiation Therapy in Journal of Drugs in Dermatology

Retrospective registry study showed a 98.9% non-recurrence rate after 85 months in subjects with non-melanoma skin cancer treated with SRT BOCA RATON, Fla. , March 03, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical…

March
03
2020

Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radio Therapy in Journal of Drugs in Dermatology

Retrospective registry study showed a 98.9% non-recurrence rate after 85 months in subjects with non-melanoma skin cancer treated with SRT BOCA RATON, Fla. , March 03, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy